Coronary disease & ACS

Sex-based differences in heart failure development during STEMI hospitalization

Eur Heart J Qual Care Clin OutcomesPublished prospective, multi-centre registry

Authors' conclusion

Women with ST-segment elevation myocardial infarction admitted in Killip class I had a higher risk of developing in-hospital HF. However, HF had a similar impact on in-hospital mortality in both sexes.

Study context

Population
STEMI patients; primary analysis in patients admitted in Killip class ISTEMI patients (22.9% women), 985 admitted in Killip class I · admitted in Killip class I 985
Participants
1,279 patients
Exposure
Sex-specific differences in the development of in-hospital heart failure (HF)
Outcome
Development of HF during hospitalization in patients initially classified as Killip class I
Follow-up
During hospitalization
Methodological detailssix teaching hospitals
  • Six teaching hospitals

Main finding

As reported in the abstract

P < 0.001

Developed HF during hospitalization, of the 985 admitted in Killip class I
45 (4.6%)

Observational data: associations, not effects.

Secondary outcomes

HF at admission

P < 0.001

HF at admission — Presented with HF at admission, of 1279
201 (15.8%)

Factors independently associated with in-hospital HF development (multi-variable logistic regression)

Female sex OR (95% CI)
3.09; 1.46-6.53
Multi-vessel disease OR (95% CI)
2.19; 1.06-4.56
Out-of-hospital cardiac arrest OR (95% CI)
4.76; 1.04-21.71
Higher left ventricular ejection fraction (protective) OR (95% CI)
0.92; 0.87-0.93
Age and final TIMI flow <3 not associated

In-hospital mortality (secondary outcome)

HF linked to increased mortality in men
  • Sex-mortality interaction P = 0.108

Original publication

Sex-based differences in heart failure development during STEMI hospitalization. Eur Heart J Qual Care Clin Outcomes. Published 31 October 2025. doi:10.1093/ehjqcco/qcaf130

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.